Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 1.266M
March 31, 2026 12.72M
December 31, 2025 19.62M
September 30, 2025 28.26M
June 30, 2025 23.55M
March 31, 2025 21.52M
December 31, 2024 13.72M
September 30, 2024 155.31M
June 30, 2024 158.38M
March 31, 2024 165.53M
December 31, 2023 185.16M
September 30, 2023 193.66M
June 30, 2023 192.95M
March 31, 2023 215.61M
December 31, 2022 230.59M
September 30, 2022 226.82M
June 30, 2022 254.04M
March 31, 2022 303.69M
December 31, 2021 335.50M
September 30, 2021 356.83M
June 30, 2021 396.87M
March 31, 2021 330.90M
December 31, 2020 316.53M
September 30, 2020 192.84M
June 30, 2020 200.79M
Date Value
March 31, 2020 132.19M
December 31, 2019 110.93M
September 30, 2019 120.22M
June 30, 2019 126.95M
March 31, 2019 105.51M
December 31, 2018 70.50M
September 30, 2018 50.67M
June 30, 2018 42.10M
March 31, 2018 36.01M
December 31, 2017 32.15M
September 30, 2017 33.02M
June 30, 2017 39.87M
March 31, 2017 29.50M
December 31, 2016 33.18M
September 30, 2016 48.38M
June 30, 2016 45.25M
March 31, 2016 26.57M
December 31, 2015 35.09M
September 30, 2015 45.53M
June 30, 2015 53.47M
March 31, 2015 56.92M
December 31, 2014 64.51M
September 30, 2014 72.64M
June 30, 2014 29.82M
March 31, 2014 30.13M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
3-D Matrix Ltd. 45.33M
Healios KK 53.98M
GNI Group Ltd. 248.83M
Agenus, Inc. -199.08M
Amgen, Inc. 11.69B

Shareholders Equity (Quarterly) Related Metrics